Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

CBX250 Is a Novel Cathepsin G Peptide-HLA-Targeting T Cell Engager That Exhibits High Tumor Antigen Selectivity and Potent Antileukemic Activity In Vivo

Blood (2024) 144 (Supplement 1): 208.

https://doi.org/10.1182/blood-2024-201699

Published: 2024

Journal Articles

AML Immunotherapy Using a Novel Tcrm-Based Bispecific Antibody That Targets a Leader Sequence Peptide Derived from Cathepsin G

Chunhua Shi, Ze Tian, Jun Yan, Mao Zhang, Pariya Sukhumalchandra, Edward Chang, Guojun Yang, Junping You, Meng Cui, Qing Shi, Anne Philips, Na Qiao, Anna Sergeeva, Lisa St. John, Hong He, Dongxing Zha, Jeffrey J. Molldrem, Gheath Alatrash

Blood (2023) 142 (Supplement 1): 1415.

https://doi.org/10.1182/blood-2023-189514

Published: 2023

Journal Articles

Targeting Myeloid Leukemia Using Novel TCR-like Chimeric Antigen Receptor-T Cells Against Cathepsin G

Jun Yan, Ze Tian, Chunhua Shi, Mao Zhang, Pariya Sukhumalchandra, Guojan Yang, Qing Edward Chang, Junping You, Meng Cui, Qing Shi, Anne Philip, Na Qiao, Anna Sergeeva, Lisa St John, Hong He, Dongxing Zha, Jeffrey J. Molldrem, Gheath Alatrash

Blood (2022) 140 (Supplement 1): 7392–7393.

https://doi.org/10.1182/blood-2022-166488

Published: 2022

Journal Articles

Predicting Response to FLT3 Inhibitors Using Genomics-Based Computational Bio-Simulation Platform

Guoliang Li, Hui Wei, Arthur Jiang, Jian Hu, Jun Yan, Linfeng Li, Jianxiang Wang

Blood (2022) 140 (Supplement 1): 7834–7835.

https://doi.org/10.1182/blood-2022-165990

Published: 2022

Journal Articles

Prophylaxis of Neutropenia with Mecapegfilgrastim in Patients with Hematologic Malignancies

Hui-qiang Huang, Zengjun Li, Gang Cheng, Gao Yan, Zhihua Yao, Guifang Zhang, Xiaoguang Wang, Zhengxiang Han, Yong Chen, Haijiao Yan, Weie Zheng, Jun Yan, Yulan Gu, Zhangxia Ren, Rusen Zhao, Ningling Zhang, Jun Ma

Blood (2021) 138 (Supplement 1): 4569.

https://doi.org/10.1182/blood-2021-149884

Published: 2021

Journal Articles

Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemia

Blood (2021) 137 (26): 3641–3655.

https://doi.org/10.1182/blood.2020007651

Published: 2021

Includes: Supplemental data

Journal Articles

Targeting AXL Kinase Sensitizes Acute Myeloid Leukemia Stem and Progenitor Cells to Venetoclax Treatment

Katharina Rothe, PhD, Xiaojia Niu, PhD, Min Chen, PhD, Rick Li, Sungeun Nam, Xiuyan Zhang, German Novakovskiy, Yehyeon Ahn, Shenshen Lai, Hong Zhang, PhD, Jun Yan, Hong Liu, Yun Zhao, PhD, Depei Wu, MDPhD, Yubin Ge, PhD, Wyeth W. Wasserman, Calvin K. Yip, Zaihui Zhang, PhD, Xiaoyan Jiang, MD PhD

Blood (2020) 136 (Supplement 1): 20.

https://doi.org/10.1182/blood-2020-140595

Published: 2020

Journal Articles

Protective Effect of Thrombopoietin on CoCl2-Induced Apoptosis of HUVEC Cells through PI3-k/Akt Pathways

Jieyu Ye, Jun-yan Wang, M.B, En-yu Liang, Mo Yang, MD PhD

Blood (2018) 132 (Supplement 1): 4969.

https://doi.org/10.1182/blood-2018-99-116094

Published: 2018

Journal Articles

Synthesis of Inflammatory Cytokines and Expression of Adhesion Molecules in Megakaryocytes

Mo Yang, MD PhD, Hui-ling Wei, M.B, Jun-yan Wang, M.B, Rui Cao, Chunfu Li, MD, Beng H Chong, MBBS, PhD

Blood (2017) 130 (Supplement 1): 4839.

https://doi.org/10.1182/blood.V130.Suppl_1.4839.4839

Published: 2017

Journal Articles

Targeting the GAS6/AXL Pathway with a Newly Developed AXL-Selective Inhibitor SLC-0211 for the Treatment of Acute Myeloid Leukemia

Xiaojia Niu, Katharina Roche, PhD, Min Chen, MD PhD, Hong Zhang, PhD, Jun Yan, Yubin Ge, PhD, Zaihui Zhang, PhD, Xiaoyan Jiang, MD PhD

Blood (2017) 130 (Supplement 1): 2640.

https://doi.org/10.1182/blood.V130.Suppl_1.2640.2640

Published: 2017

Journal Articles

The Early Rejection of Allogeneic BMC by Macrophages or NK Cells Is TRIF Signaling Dependent

Hong Xu, MD, Jun Yan, MD, PhD, Yiming Huang, MD, Suzanne T Ildstad

Blood (2012) 120 (21): 1883.

https://doi.org/10.1182/blood.V120.21.1883.1883

Published: 2012

Journal Articles

Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans

Chunjian Qi, Yihua Cai, Lacey Gunn, Chuanlin Ding, Bing Li, Goetz Kloecker, Keqing Qian, John Vasilakos, Shinobu Saijo, Yoichiro Iwakura, John R. Yannelli, Jun Yan

Blood (2011) 117 (25): 6825–6836.

https://doi.org/10.1182/blood-2011-02-339812

Published: 2011

Includes: Supplemental data

Journal Articles

A Critical Role for Innate Immunity In Allogeneic Hematopoietic Cell Rejection Via the TLR4/TRIF Pathway

Hong Xu, MD, Jun Yan, MD, PhD, Ziqiang Zhu, MD, Yiming Huang, MD, Yujie Wen, MD, PhD, Larry D Bozulic, PhD, Suzanne T. Ildstad, MD

Blood (2010) 116 (21): 77.

https://doi.org/10.1182/blood.V116.21.77.77

Published: 2010

Journal Articles

Innate Immunity Is Responsible for Early Allorejection of Donor Bone Marrow Cells.

Hong Xu, M.D., Jun Yan, Ziqiang Zhu, Lala-Rukh Hussain, B.S., Yiming Huang, M.D., Larry D. Bozulic, PhD, Suzanne T Ildstad

Blood (2009) 114 (22): 3523.

https://doi.org/10.1182/blood.V114.22.3523.3523

Published: 2009

Journal Articles

Bone Marrow Cell Rejection by Innate Immune Pathways Is Exclusively Dependent On the TRIF Pathway.

Hong Xu, M.D., Jun Yan, Ziqiang Zhu, Lala-Rukh Hussain, B.S., Yiming Huang, M.D., Yujie Wen, Ph.D, Suzanne T Ildstad

Blood (2009) 114 (22): 3526.

https://doi.org/10.1182/blood.V114.22.3526.3526

Published: 2009

Journal Articles

Genetics and Epigenetics of the PU.1 Upstream Regulatory Element: AML1 Binding Sites Are Critical for Leuekmia Induced by the AML/ETO9a Fusion Oncogene

Pu Zhang, MD, Gang Huang, Alex Ebralidze, Jun-Yan Zhang, Annalisa DiRuscio, Chris Hetherington, Elena Levantini, Daniel G. Tenen

Blood (2008) 112 (11): 594.

https://doi.org/10.1182/blood.V112.11.594.594

Published: 2008

Journal Articles

Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1

Chuanlin Ding, Li Wang, Jose Marroquin, Jun Yan

Blood (2008) 112 (7): 2817–2825.

https://doi.org/10.1182/blood-2008-05-157396

Published: 2008

Journal Articles

Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization

Hong Xu, Jun Yan, Yiming Huang, Paula M. Chilton, Chuanlin Ding, Carrie L. Schanie, Li Wang, Suzanne T. Ildstad

Blood (2008) 111 (6): 3266–3275.

https://doi.org/10.1182/blood-2006-10-053801

Published: 2008

Includes: Supplemental data

Journal Articles

Xenotransplantation: a step closer to reality?

Hong Xu, Jun Yan, Suzanne T. Ildstad

Blood (2007) 110 (12): 3815.

https://doi.org/10.1182/blood-2007-08-103820

Published: 2007

Journal Articles

CD154:CD40 Co-Stimulatory Blockade: A Specific Approach To Prevent Sensitization to Donor Alloantigens.

Hong Xu, MD, Jun Yan, MD, PhD, Suzanne T. Ildstad, MD

Blood (2007) 110 (11): 2246.

https://doi.org/10.1182/blood.V110.11.2246.2246

Published: 2007

NARROW

CBX250 Is a Novel Cathepsin G Peptide-HLA-Targeting T Cell Engager That Exhibits High Tumor Antigen Selectivity and Potent Antileukemic Activity In Vivo

AML Immunotherapy Using a Novel Tcrm-Based Bispecific Antibody That Targets a Leader Sequence Peptide Derived from Cathepsin G

Targeting Myeloid Leukemia Using Novel TCR-like Chimeric Antigen Receptor-T Cells Against Cathepsin G

Predicting Response to FLT3 Inhibitors Using Genomics-Based Computational Bio-Simulation Platform

Prophylaxis of Neutropenia with Mecapegfilgrastim in Patients with Hematologic Malignancies

Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemia

Targeting AXL Kinase Sensitizes Acute Myeloid Leukemia Stem and Progenitor Cells to Venetoclax Treatment

Protective Effect of Thrombopoietin on CoCl2-Induced Apoptosis of HUVEC Cells through PI3-k/Akt Pathways

Synthesis of Inflammatory Cytokines and Expression of Adhesion Molecules in Megakaryocytes

Targeting the GAS6/AXL Pathway with a Newly Developed AXL-Selective Inhibitor SLC-0211 for the Treatment of Acute Myeloid Leukemia

The Early Rejection of Allogeneic BMC by Macrophages or NK Cells Is TRIF Signaling Dependent

Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans

A Critical Role for Innate Immunity In Allogeneic Hematopoietic Cell Rejection Via the TLR4/TRIF Pathway

Innate Immunity Is Responsible for Early Allorejection of Donor Bone Marrow Cells.

Bone Marrow Cell Rejection by Innate Immune Pathways Is Exclusively Dependent On the TRIF Pathway.

Genetics and Epigenetics of the PU.1 Upstream Regulatory Element: AML1 Binding Sites Are Critical for Leuekmia Induced by the AML/ETO9a Fusion Oncogene

Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1

Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization

Xenotransplantation: a step closer to reality?

CD154:CD40 Co-Stimulatory Blockade: A Specific Approach To Prevent Sensitization to Donor Alloantigens.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only